Proactive Investors: CytoDyn expects to exceed 75-patient enrollment in its coronavirus-focused Phase 2 clinical trial Jun 15, 2020
Proactive Investors: CytoDyn continues to works on licensing deals as FDA continues its review on patient data Jun 5, 2020
Latest from Montefiore: A promising drug for the treatment of severe lung inflammation in COVID-19 patients May 25, 2020
Proactive Investors: CytoDyn to work with Mexican National Institutes of Health to treat coronavirus patients May 20, 2020
Proactive Investors: CytoDyn to submit trial designs of remdesivir vs leronlimab and in combination to battle coronavirus May 18, 2020
Fox News: Biotech eyes COVID-19 treatment trial combining experimental coronavirus drugs leronlimab, remdesivir May 18, 2020
Dr. Yo – Leronlimab, RANTES, COVID-19 (Coronavirus) Discussion with Dr. Bruce Patterson of IncellDX May 17, 2020
